Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sui-Yuan Chang and Han-Chieh Kao.
Sui-Yuan Chang
Connection Strength
0.582
Han-Chieh Kao
  1. Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses. Sci Rep. 2021 04 22; 11(1):8692.
    View in: PubMed
    Score: 0.235
  2. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. mBio. 2021 08 31; 12(4):e0058721.
    View in: PubMed
    Score: 0.060
  3. Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Antimicrob Agents Chemother. 2021 03 18; 65(4).
    View in: PubMed
    Score: 0.058
  4. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives. Front Pharmacol. 2020; 11:606097.
    View in: PubMed
    Score: 0.057
  5. Enhancement of the IFN-ß-induced host signature informs repurposed drugs for COVID-19. Heliyon. 2020 Dec; 6(12):e05646.
    View in: PubMed
    Score: 0.057
  6. Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection. EMBO Mol Med. 2021 01 11; 13(1):e12828.
    View in: PubMed
    Score: 0.057
  7. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. Cell Rep. 2020 10 13; 33(2):108254.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.